Hepion Pharmaceuticals, Inc. (HEPA)
Market Open
12 Aug, 19:06
NASDAQ (CM) NASDAQ (CM) Primary $
0. 05
0
0%
$
558.9K Market Cap
- P/E Ratio
- Div Yield
942 Volume
-10.98 Eps
$ 0.05
Previous Close Want to track HEPA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | 132.77 |
| | | - | - |
HEPA Earnings Reports FAQ
What is the earnings per share (EPS) for HEPA?
The current EPS is -10.98.
What is the company's earnings growth rate?
Hepion Pharmaceuticals, Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Hepion Pharmaceuticals, Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Hepion Pharmaceuticals, Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for HEPA at this time, as Hepion Pharmaceuticals, Inc has no recent EPS data to calculate it.
